T 1656/13 (Antibodies for identifying and/or isolating haematopoietic stem cells/HOFFMANN-LA ROCHE) of 19.09.2019
- European Case Law Identifier
- ECLI:EP:BA:2019:T165613.20190919
- Date of decision
- 19 September 2019
- Case number
- T 1656/13
- Petition for review of
- -
- Application number
- 03019221.5
- IPC class
- C07K 16/28C12N 5/07
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Antibodies for identifying and/or isolating at least one cell population which is selected from the group comprising haematopoietic stem cells, neuronal stem cells, neuronal precursor cells, mesenchymal stem cells and mesenchymal precursor cells
- Applicant name
- F. Hoffmann-La Roche AG
- Opponent name
- UCB Pharma S.A.
Wilex AG - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention R 115(2)Rules of procedure of the Boards of Appeal Art 15(3)
- Keywords
- Main request, auxiliary request 1: amendments - undisclosed disclaimer - allowable (no)
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.